Airway Management During TCI vs RSI Anesthesia Induction
Airway Management and Safety Aspects During Target Controlled Infusion (TCI) Compared to Rapid Sequence Induction (RSI) of Anesthesia in Non-cardiac Surgery
1 other identifier
observational
70
1 country
1
Brief Summary
The aims of this observational study is to evaluate and compare feasibility of airway management during standardized TCI and RSI anesthesia induction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 25, 2018
CompletedFirst Posted
Study publicly available on registry
October 29, 2018
CompletedStudy Start
First participant enrolled
October 29, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 22, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2019
CompletedSeptember 26, 2019
September 1, 2019
4 months
October 25, 2018
September 25, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Safety time for apnea
measurement of length of period for apnea during TCI and RSI induction by a timer
10min
Secondary Outcomes (1)
Duration of spontaneous breathing
10min
Interventions
Standardized TCI and RSI anesthesia induction
Eligibility Criteria
Consecutive cohort, electively scheduled for breast cancer surgery, endocrinological surgery (thyroid, parathyroid) and minor general abdominal surgery.
You may qualify if:
- signed informed consent
- BMI \< 35 kg/m2
- preoperative assessment accepted by consultant anesthesiologist
- scheduled for breast cancer surgery, endocrinological surgery (thyroid, parathyroid) or minor general abdominal surgery.
You may not qualify if:
- not signed consent
- instable angina pectoris
- severe bronchial asthma
- severe chronic obstructive pulmonary disease
- dementia
- severe heart valve disease
- severe renal failure
- body mass index \> 35 kg/m2
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Umeå Universitylead
Study Sites (1)
Sunderby teaching hospital
Luleå, 97180, Sweden
Study Officials
- PRINCIPAL INVESTIGATOR
Tomi Myrberg, MD PhD
Umea University, senior lecturer
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior lecturer, MD PhD
Study Record Dates
First Submitted
October 25, 2018
First Posted
October 29, 2018
Study Start
October 29, 2018
Primary Completion
February 22, 2019
Study Completion
May 31, 2019
Last Updated
September 26, 2019
Record last verified: 2019-09
Data Sharing
- IPD Sharing
- Will not share